The Association for Accessible Medicines filed the suit in U.S. District Court, calling the measure “an unconstitutional overreach.”
“Rather than allow the vibrant competition in the generic drug marketplace to continue working for patients, Maryland would become the first state to reject generic competition in favor of more government regulation,” said AAM’s CEO Chip Davis.
Under the law, which is set to take effect in October, Maryland’s attorney general would have the power to bring civil actions against manufacturers of off-patent or generic drugs that make “unconscionable” price increases.
More
1 comment:
Raise the price of a previously inexpensive generic drug 700% or more and look for Maryland to ask the courts to ask you why. Your answer had better be very compelling.
Post a Comment